Pages without language links

From The Embassy of Good Science

The following pages do not link to other language versions.

50 rwikis ordered by recently added

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
  1. Teaching sensitive and controversial issues in divided societies
  2. Ignoring substantial safety risks of studies
  3. Polarized research
  4. Conducting research in high risk locations
  5. Imposter Syndrome
  6. Ethical considerations in dealing with human remains
  7. The ethics of managing a laboratory or research group
  8. Posing irrelevant research questions
  9. Anonymous Authorship
  10. Publication
  11. Gender bias
  12. Forensic Statistics to detect Data Fabrication
  13. Importance of healthy lifestyle
  14. Questionable Research Practices in Analysis and Reporting
  15. Ethical Challenges of AI-Driven Neurotechnology Devices
  16. Predatory publishing
  17. How to be a good lab partner
  18. Retractions: correcting the scientific literature
  19. Qualitative research
  20. Virtues in research integrity
  21. Privacy in research
  22. Inappropriate authorship
  23. Grading the quality of evidence in clinical practice guidelines
  24. Research Integrity champions
  25. Selective citation
  26. The decision on ice
  27. Insufficiently reported study flaws and limitations
  28. Faking it in academia- the rise of authorship fraud
  29. Prospective registration of clinical trials
  30. Fabrication
  31. The impact of the GDPR on scientific data
  32. The Rise of Octopus Affiliation: Navigating Multiple Institutional Associations in Academic Publishing
  33. Dialogue versus debate
  34. Initiatives promoting research integrity
  35. Dutch National Survey on Research Integrity
  36. Collaboration In Research
  37. Discipline specific codes and guidelines on research integrity
  38. Monitoring funding processes
  39. Data management plans
  40. Consent and assent for research on children
  41. The learning curve - theatre play #MeTooAcademia
  42. P-value hacking
  43. Convenience sampling as an ethical concern
  44. Conflict of interests
  45. The influence of pharmaceutical company on drug availability
  46. Science policy
  47. Consent and Assent for Research on Children
  48. Poor mentoring or supervision of early career researcherers
  49. Networks and projects promoting research integrity
  50. Sponsorship of drug and device studies by the manufacturing company
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
5.7.3